These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26890998)

  • 1. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
    Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP
    J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
    Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
    PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
    Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
    J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
    Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
    Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Tarantula Venom-Derived Na
    Wu B; Murray JK; Andrews KL; Sham K; Long J; Aral J; Ligutti J; Amagasu S; Liu D; Zou A; Min X; Wang Z; Ilch CP; Kornecook TJ; Lin MJ; Be X; Miranda LP; Moyer BD; Biswas K
    J Med Chem; 2018 Nov; 61(21):9500-9512. PubMed ID: 30346167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a).
    Minassian NA; Gibbs A; Shih AY; Liu Y; Neff RA; Sutton SW; Mirzadegan T; Connor J; Fellows R; Husovsky M; Nelson S; Hunter MJ; Flinspach M; Wickenden AD
    J Biol Chem; 2013 Aug; 288(31):22707-20. PubMed ID: 23760503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
    Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
    Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
    Murray JK; Biswas K; Holder JR; Zou A; Ligutti J; Liu D; Poppe L; Andrews KL; Lin FF; Meng SY; Moyer BD; McDonough SI; Miranda LP
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4866-4871. PubMed ID: 26112439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of highly potent and selective HNTX-III mutant against hNa
    Zhang Y; Wang L; Peng D; Zhang Q; Yang Q; Li J; Li D; Tang D; Chen M; Liang S; Liu Y; Wang S; Liu Z
    J Biol Chem; 2021; 296():100326. PubMed ID: 33493520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
    Agwa AJ; Peigneur S; Chow CY; Lawrence N; Craik DJ; Tytgat J; King GF; Henriques ST; Schroeder CI
    J Biol Chem; 2018 Jun; 293(23):9041-9052. PubMed ID: 29703751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
    Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
    J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Antibody Reactivity for Efficient Derivatization to Generate Na
    Biswas K; Nixey TE; Murray JK; Falsey JR; Yin L; Liu H; Gingras J; Hall BE; Herberich B; Holder JR; Li H; Ligutti J; Lin MJ; Liu D; Soriano BD; Soto M; Tran L; Tegley CM; Zou A; Gunasekaran K; Moyer BD; Doherty L; Miranda LP
    ACS Chem Biol; 2017 Sep; 12(9):2427-2435. PubMed ID: 28800217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNa
    Zhang Y; Yang Q; Zhang Q; Peng D; Chen M; Liang S; Zhou X; Liu Z
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30181499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
    Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
    Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.
    Agwa AJ; Tran P; Mueller A; Tran HNT; Deuis JR; Israel MR; McMahon KL; Craik DJ; Vetter I; Schroeder CI
    J Biol Chem; 2020 Apr; 295(15):5067-5080. PubMed ID: 32139508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant.
    Rahnama S; Deuis JR; Cardoso FC; Ramanujam V; Lewis RJ; Rash LD; King GF; Vetter I; Mobli M
    PLoS One; 2017; 12(3):e0173551. PubMed ID: 28301520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1.
    Lawrence N; Wu B; Ligutti J; Cheneval O; Agwa AJ; Benfield AH; Biswas K; Craik DJ; Miranda LP; Henriques ST; Schroeder CI
    ACS Chem Biol; 2019 Jan; 14(1):118-130. PubMed ID: 30507158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.
    Klint JK; Smith JJ; Vetter I; Rupasinghe DB; Er SY; Senff S; Herzig V; Mobli M; Lewis RJ; Bosmans F; King GF
    Br J Pharmacol; 2015 May; 172(10):2445-58. PubMed ID: 25754331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.